Following the onset of CHF, obesity per se is associated with higher skeletal muscle mass and tissue ATP production, lower mitochondrial ROS production, improved redox state, cytokine profile and insulin signaling. The gene discussed is INS; the disease is obesity due to melanocortin 4 receptor deficiency.